A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome

Molecular Immunology

Volumn 47, Issue 7-8, 2010, Pages 1629-1634

  Papanastasiou, Anastasios D ^a   Mantagos, Stefanos ^a   Papanastasiou, Dimitrios A ^a   Zarkadis, Ioannis K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

DNA binding domain; Hyper IgE syndrome; ROR t; STAT3 mutation

Indexed keywords

ARGININE; ASPARTIC ACID; GLYCINE; GUANINE; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CHILD; DNA BINDING; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HUMAN; HYPER IGM SYNDROME; IMMUNOSTIMULATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; TH17 CELL; UNTRANSLATED REGION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CHILD; DNA; FEMALE; HETEROZYGOTE; HUMANS; JOB'S SYNDROME; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; NUCLEIC ACID CONFORMATION; SEQUENCE ALIGNMENT; STAT3 TRANSCRIPTION FACTOR;

EID: 77950626754     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.01.010     Document Type: Article

References (20)

1. Becker S., Groner B., Müller C.W. Three-dimensional structure of the Stat3b homodimer bound to DNA. Nature 1998, 394:145-151.
2. Freeman A.F., Collura-Burke C.J., Patronas N.J., Ilcus L.S., Darnell D., Davis J., Puck J.M., Holland S.M. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007, 119:e1121-e1125.
3. Grimbacher B., Holland S.M., Gallin J.I., Greenberg F., Hill S.C., Malech H.L., Miller J.A., O'Connell A.C., Puck J.M. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, 340:692-702.
4. Grimbacher B., Holland S.M., Puck J.M. Hyper-IgE syndromes. Immunol. Rev. 2005, 203:244-250.
5. Grimbacher B., Schäffer A.A., Holland S.M., Davis J., Gallin J.I., Malech H.L., Atkinson T.P., Belohradsky B.H., Buckley R.H., Cossu F., Español T., Garty B.Z., Matamoros N., Myers L.A., Nelson R.P., Ochs H.D., Renner E.D., Wellinghausen N., Puck J.M. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am. J. Hum. Genet. 1999, 65:735-744.
6. Harris T.J., Grosso J.F., Yen H.R., Xin H., Kortylewski M., Albesiano E., Hipkiss E.L., Getnet D., Goldberg M.V., Maris C.H., Housseau F., Yu H., Pardoll D.M., Drake C.G. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 2007, 179:4313-4317.
7. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schäffer A.A., Puck J.M., Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 2007, 357:1608-1619.
8. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
9. Jiaoa H., Tóthb B., Erdos M., Franssona I., Rákóczi E., Baloghc I., Magyarics Z., Dérfalvi B., Csorbab G., Szaflarskaf A., Megarbaneg A., Akatcherianh C., Dbaiboi G., Rajnavölgyid E., Hammarströmj L., Kerea J., Lefranck G., Maródi L. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol. Immunol. 2008, 46:202-206.
10. Kim H.J., Kim J.H., Shin Y.K., Lee S.I., Ahn K.M. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome. J. Allergy Clin. Immunol. 2009, 123:956-958.
11. Ling J.C., Freeman A.F., Gharib A.M., Arai A.E., Lederman R.J., Rosing D.R., Holland S.M. Coronary artery aneurysms in patientswith hyper IgE recurrent infection syndrome. Clin. Immunol. 2007, 122:255-258.
12. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., Fulcher D.A., Tangye C.G., Cook M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 2008, 205:1551-1557.
13. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
14. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., Davis J., Hsu A., Asher A.I., O'Shea J., Holland S.M., Paul1 W.E., Douek D.C. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
15. Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K., Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., Kaneko H., Kondo N., Tsuge I., Yachie A., Sakiyama Y., Iwata T., Bessho F., Ohishi T., Joh K., Imai K., Kogawa K., Shinohara M., Fujieda M., Wakiguchi H., Pasic S., Abinun M., Ochs H.D., Renner E.D., Jansson A., Belohradsky B.H., Metin A., Shimizu N., Mizutani S., Miyawaki T., Nonoyama S., Karasuyama H. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquire immunity. Immunity 2006, 25:745-755.
16. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., Tsuge I., Karasuyama H. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J. Exp. Med. 2009, 206:1291-1301.
17. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., Karasuyama H. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
18. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
19. Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., Zhu O., Jansson A.F., Barboza J., Schimke L.F., Leppert M.F., Getz M.M., Seger R.A., Hill H.R., Belohradsky B.H., Torgerson T.R., Ochs H.D. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 2008, 122:181-187.
20. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL 17-producing T cells. Immunity 2006, 24:179-189.